Request for COVID Vaccine Prioritization

Life Science Washington submitted the letter below to theWashington Department of Health requesting that two groups of high-risk essential life science employees be prioritized for early access to COVID-19 vaccines.  Our letter is consistent with BIO and AdvaMed requests for prioritization in the CDC’s Advisory Council on Immunization Practices (ACIP) framework.

Access the letter here.

Posted on Updated:
Share:
Related Resources
  • Industry Reports
  • 2025

Washington State Life Science Investment Report – September 2025
  • Industry Reports
  • 2025

Washington State Life Science Investment Report – August 2025
  • Policy Blog
  • 2025

Policy Blog – September 19, 2025 – After Months of Advocacy, Appropriators Fully Fund NIH

Life Science Washington traveled to Washington, DC this week as part of a multi-state fly-in that we co-organized to press Congress on two urgent priorities: fully funding the National Institutes of Health (NIH) and reauthorizing the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. At our Capitol Hill briefing, Safeguarding Innovation: […]
  • Industry Reports
  • 2025

Washington State Life Science Investment Report – July 2025